Related Experiment Video

Updated: Aug 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy

Tracy A McGowan1, Yanqing Zhu, Kumar Sharma

  • 1Dorrance Hamilton Research Laboratories, Division of Nephrology, Center for Diabetic Kidney Disease, Thomas Jefferson University Hospital, 1020 Locust Street, Suite 353, Philadelphia, PA 19107, USA.

Current Diabetes Reports
|November 13, 2004
PubMed

Insights

Diabetic nephropathy, a growing concern, involves matrix accumulation driven by transforming growth factor-beta (TGF-beta). Blocking TGF-beta shows promise in treating this kidney disease, with pirfenidone as a potential new therapy.

Area of Science:

  • Nephrology
  • Diabetology
  • Fibrosis Research

Background:

  • Diabetic nephropathy incidence is increasing despite glycemic and blood pressure control.
  • Matrix accumulation in diabetic kidneys is primarily driven by transforming growth factor-beta (TGF-beta).

Purpose of the Study:

  • To review the role of TGF-beta in diabetic kidney disease.
  • To discuss current and novel therapeutic strategies, including antifibrotic agents.

Main Methods:

  • Review of recent scientific literature on TGF-beta signaling in diabetic nephropathy.
  • Analysis of studies investigating antifibrotic strategies and their hemodynamic effects.

Main Results:

  • Blocking TGF-beta effectively reduces matrix accumulation in diabetic kidneys.
  • TGF-beta inhibition demonstrates beneficial hemodynamic effects relevant to diabetic complications.

Conclusions:

  • TGF-beta plays a critical role in the pathogenesis of diabetic nephropathy.
  • Antifibrotic therapies targeting TGF-beta, such as pirfenidone, hold significant clinical potential for managing diabetic kidney disease.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...